Literature DB >> 3280160

Ocular allergy.

M R Allansmith, R N Ross.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3280160     DOI： 10.1111/j.1365-2222.1988.tb02837.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN： 0009-9090


× No keyword cloud information.
  13 in total

1.  Chemokines in the limbal form of vernal keratoconjunctivitis.

Authors:  A M Abu El-Asrar; S Struyf; S A Al-Kharashi; L Missotten; J Van Damme; K Geboes
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

Review 2.  Allergic eye disease mechanisms.

Authors:  J I McGill; S T Holgate; M K Church; D F Anderson; A Bacon
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

3.  Effect of pollen-mediated oxidative stress on immediate hypersensitivity reactions and late-phase inflammation in allergic conjunctivitis.

Authors:  Attila Bacsi; Nilesh Dharajiya; Barun K Choudhury; Sanjiv Sur; Istvan Boldogh
Journal:  J Allergy Clin Immunol       Date:  2005-08-19       Impact factor: 10.793

4.  Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

Authors:  Najam A Sharif
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-05

5.  NPR-B natriuretic peptide receptors in human corneal epithelium: mRNA, immunohistochemistochemical, protein, and biochemical pharmacology studies.

Authors:  Parvaneh Katoli; Najam A Sharif; Anupam Sule; Slobodan D Dimitrijevich
Journal:  Mol Vis       Date:  2010-07-07       Impact factor: 2.367

6.  Alpha-1 antitrypsin, a diagnostic and prognostic marker of vernal keratoconjunctivitis.

Authors:  Akif Ahsan; Khushtar A Salman; Sana Alam; Anwar H Siddiqui; Syed Shariq Naeem; Aquil Ahmad; Iqbal M Khan
Journal:  J Clin Diagn Res       Date:  2014-05-15

7.  Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis.

Authors:  M Kidd; S H McKenzie; I Steven; C Cooper; R Lanz
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

Review 8.  Therapeutic options in ocular allergic disease.

Authors:  M Hingorani; S Lightman
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

9.  A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis.

Authors:  M el Hennawi
Journal:  Br J Ophthalmol       Date:  1994-05       Impact factor: 4.638

10.  Human conjunctival epithelial cell responses to platelet-activating factor (PAF): signal transduction and release of proinflammatory cytokines.

Authors:  Najam A Sharif; Shouxi Xu; Peggy E Hellberg; Iok-Hou Pang; Daniel A Gamache; John M Yanni
Journal:  Mol Vis       Date:  2009-06-06       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.